Remon J, Girard N, Novello S, de Castro J, et al. PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. Clin Lung Cancer 2022;23:e243-e246.
PMID: 34393061